Prologue Medicines Revenue and Competitors

USA

Location

#6943

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Prologue Medicines's estimated annual revenue is currently $5.1M per year.(i)
  • Prologue Medicines's estimated revenue per employee is $155,000
  • Prologue Medicines's total funding is $50M.

Employee Data

  • Prologue Medicines has 33 Employees.(i)
  • Prologue Medicines grew their employee count by 94% last year.

Prologue Medicines's People

NameTitleEmail/Phone
1
VP and Head BiologyReveal Email/Phone
2
VP, Head PlatformReveal Email/Phone
3
Head Strategy and OperationsReveal Email/Phone
4
SVP, Head Computational Biology and AI SciencesReveal Email/Phone
5
VP and Head PlatformReveal Email/Phone
6
Director, Head Data ScienceReveal Email/Phone
7
Senior Lab Operations and Office ManagerReveal Email/Phone
8
Research AssociateReveal Email/Phone
9
Senior Scientist I, Computational Structural BiologyReveal Email/Phone
10
Principal Scientist, Computational Data ScienceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$9.1M59-9%N/AN/A
#10
$16.6M1073%N/AN/A
Add Company

What Is Prologue Medicines?

Prologue is designing powerful new medicines by unlocking the viral proteome. The company’s state-of-the-art DELVE™ Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021.

keywords:N/A

$50M

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

94%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M33-20%N/A
#2
$6M33-23%N/A
#3
N/A3338%N/A
#4
$3.8M33N/AN/A
#5
$7.1M33N/AN/A